Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TSE:IFC

Intact Financial (IFC.TO)

277.96
-0.26 (0.09%)
as of Jun 19, 2026, 8:00:01 pm Market Open.
246 watching
0
BUY ON WEAKNESS
Well run. He's a happy customer. A consolidator. Stock's range bound, but at high levels. Fully valued. On his list, so if it got hurt, he'd take a look. Overall, rising rates will not have a material impact on its business.
PAST TOP PICK
(A Top Pick Jan 29/21, Up 19%) Beat last quarter by 64%. Bought RSA, with an 8% accretion rate. Trading around 14.3x. Still a very good, long-term story. A lot of catastrophe losses, but they've managed that part of the business well.
TOP PICK
Largest P&C insurer in Canada. 21% market share. Efficient operations. Consistent profitability, 5% above that of industry rivals. Consolidator. Now on the map in the UK and Ireland. Longer term, climate change and rising property values advantage them. Yield is 2%. (Analysts’ price target is $196.08)
PAST TOP PICK
(A Top Pick Nov 05/20, Up 16%) It's a major holding of his. They're an excellent insurance operator. They're a leader in digital insurance in Canada with over 400 AI experts. This drives organic growth. They invest the float conservatively, and they are good acquirers, most recently getting a toehold in the UK and Scandinavia. They are gaining market share in Canada, too. The insurance market now has "hard" conditions, meaning pricing power as premiums rise. So, there's strong earnings growth.
TOP PICK
A steady eddy. They just did an acquisition of RSA which expand their leadership in Canada, and gives them a presence in the UK and Ireland. Tailwinds come from their high-quality investment porfolio. They enjoy good pricing in various divisions as we leave Covid behind. He see EPS growth. Trades at 16.3x future PE. (Analysts’ price target is $189.64)
BUY ON WEAKNESS
Great stock over the years, acquiring and consolidating. Great business, well managed. Tremendous pricing power in the industry. Richly valued. Good one to own long term, quality company. Try to buy it on the rare dips, when there's a market correction.
PAST TOP PICK
(A Top Pick Jun 11/20, Up 29%) Capable acquirers. Recent acquisitions are expected to be accretive. Good environment for P&C insurers. By far, best in breed in Canada, maybe in NA.
PAST TOP PICK
(A Top Pick Jun 12/20, Up 22%) Would buy this again. On an EPS profile, he sees 15% growth. Trading at 15.4x 2022 right now. Price to growth, it is compelling. Closing a big acquisition in June. The multiple will expand once they show signs of incorporating the acquisition well.
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. It has pulled back in the last seven days of trading. It completed a bond offering. Price targets were cut by BMO. The drop seems related to the market more than anything company specific. Earnings remain good and the stock is up year to date. Fairly attractive at these prices. Unlock Premium - Try 5i Free

HOLD
Very well run. Fundamentals in the P&C insurance industry are very positive. It's a "hard market", so they're enjoying significant price increases and more volume across different lines of business. Currently making a pretty significant acquisition.
PAST TOP PICK
(A Top Pick Mar 11/20, Up 20%) Recommended this on the eve of covid. Wanted something steady and it did well. They bought RSA in Q2 that gives value to shareholders. Still a fragmented business and has good upside potential. Trading at 12x 2023. Still likes it.
BUY
Very well run company, but would consider it if the price were 15% lower. You can buy this and do well over several years. Happy to recommend it. Their combined ratio has always been on the positive side.
TOP PICK
Dominant property and casualty insurer with 17% market share in home, auto, commercial and specialty lines. They are going through a $12B acquisition that will give them a presence in the UK. Longer-term forces like climate change and rising property values give them higher premiums and higher insured values. There is a hardening market in their insurance space. (Analysts’ price target is $181.78)
BUY
Fundamentals are very strong. Investors are unsure about recent RSA acquisition. Undervalued at these levels. Great opportunity to buy. Great story. Good strong dividend payer. Will execute well on the RSA deal.
BUY ON WEAKNESS
The stock has been a high performer in recent years, so it's cooling down now and testing support levels. That is not the worst thing, though. It remains well-run and continues to dominate market share. As it consolidates with this European acquisition, watch it. As Intact touches the 50- or 200-day moving average, buy it.
Showing 31 to 45 of 218 entries